<DOC>
	<DOCNO>NCT00170443</DOCNO>
	<brief_summary>This study compare safety immunogenicity three different dose level experimental recombinant influenza HA protein vaccine standard inactivate influenza vaccine heallthy elderly subject age 65-80 . Blood nasal secretion assessment antibody response obtain subject prior one month vaccination .</brief_summary>
	<brief_title>Trivalent rHA Dose Escalation Study Elderly Subjects</brief_title>
	<detailed_description>Approximately 400 healthy , ambulatory adult age 65-80 randomize one four study group receive single immunization license trivalent inactivate influenza vaccine one three dose level investigatioanl trivalent recombinant influenza HA protein vaccine . The study conduct 2 stage . In first stage , 80 subject randomize ( 20 per group ) receive one vaccination Day 0 . Safety evaluate Stage 1 subject complete 7 day follow-up . Enrollment Stage 2 subject begin safety data Stage 1 review . In Stage 2 , 320 subject randomize ( 80 per group ) receive one vaccination Day 0 . Blood nasal secretion collect prior approximately one month vaccination ass antibody response .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Medically stable adult age 65 80 . Able give inform consent . Able comply study procedure . Community dwell . History immunodeficiency treatment immunosuppressive medication . ( use inhale steroid topical steroid consider immunosuppressive ) . Allergy egg , egg protein , thimerosal , vaccine component . Acute febrile illness upper respiratory tract illness within 72 hour vaccination . Life expectancy le 6 month . Use experimental vaccine medication within one month study entry . Receipt parenteral immunoglobulin within one month study entry . Any acute chronic condition opinion investigator would render vaccination unsafe interfere evaluation response .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2006</verification_date>
	<keyword>Influenza , Baculovirus , Immunogenicity , Geriatrics</keyword>
</DOC>